Ravulizumab 61434-0076
Product NDC
61434-0076- Manufacturer
- Catalent Indiana, Llc
- Dosage Form
- Injection, Solution
- Product Type
- Drug For Further Processing
- Marketing Start
- January 1, 2025
- Listing Expires
- December 31, 2027
Active Ingredients
| Ingredient | Strength |
|---|---|
| Ravulizumab | 100 mg/mL |
Packaging Options(2)
480 VIAL in 1 CASE (61434-076-00) / 3 mL in 1 VIAL
288 VIAL in 1 CASE (61434-076-01) / 11 mL in 1 VIAL